-
公开(公告)号:US20240398809A1
公开(公告)日:2024-12-05
申请号:US18405453
申请日:2024-01-05
Applicant: LEO PHARMA A/S , Japan Tobacco Inc.
Inventor: Michael SIERRA , Tord LABUDA , Atsuo TANIMOTO , Yuichi SHINOZAKI
IPC: A61K31/519 , A61K9/00 , A61K9/06 , A61K47/06 , A61P17/14
Abstract: The present invention provides a novel treatment of alopecia areate. The problem to be solved by the invention is to provide a new pharmaceutical use of 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-ox-opropanenitrile. A therapeutic or preventive agent for alopecia areata, containing 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro-[3.4]octan-1-yl]-3-oxopropanenitrile as an active ingredient.
-
公开(公告)号:US20180263986A1
公开(公告)日:2018-09-20
申请号:US15762188
申请日:2016-09-22
Applicant: LEO Pharma A/S , Japan Tobacco Inc.
Inventor: Michael SIERRA , Tord LABUDA , Atsuo TANIMOTO , Yuichi SHINOZAKI
IPC: A61K31/519 , A61P17/14 , A61K9/00
CPC classification number: A61K31/519 , A61K9/0014 , A61K9/06 , A61K47/06 , A61P17/14
Abstract: The present invention provides a novel treatment of alopecia areate. The problem to be solved by the invention is to provide a new pharmaceutical use of 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile. A therapeutic or preventive agent for alopecia areata, containing 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile as an active ingredient.
-
公开(公告)号:US20220088020A1
公开(公告)日:2022-03-24
申请号:US17228831
申请日:2021-04-13
Applicant: LEO PHARMA A/S , Japan Tobacco Inc.
Inventor: Michael SIERRA , Tord LABUDA , Atsuo TANIMOTO , Yuichi SHINOZAKI
IPC: A61K31/519 , A61K9/00 , A61K47/06 , A61K9/06 , A61P17/14
Abstract: The present invention provides a novel treatment of alopecia areate. The problem to be solved by the invention is to provide a new pharmaceutical use of 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile. A therapeutic or preventive agent for alopecia areata, containing 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile as an active ingredient.
-
-